Functional status and quality of life in older patients with advanced esophageal squamous cell cancer receiving second-line nivolumab ± ipilimumab therapy: A post hoc analysis of the phase 2, multicenter RAMONA study.

Li M, Meindl-Beinker NM, Maenz M, Betge J, Schulte N, Zhan T, Hofheinz RD, Vogel A, Angermeier S, Bolling C, de Wit M, Jakobs R, Karthaus M, Stocker G, Thuss-Patience P, Leidig T, Bauer H, Ebert MP, Haertel N

Open source

DOI: 10.1016/j.jgo.2024.101838
Published: 2024 Sep
Container: Journal of geriatric oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jgo.2024.101838,
  title = {Functional status and quality of life in older patients with advanced esophageal squamous cell cancer receiving second-line nivolumab ± ipilimumab therapy: A post hoc analysis of the phase 2, multicenter RAMONA study.},
  author = {Li M and Meindl-Beinker NM and Maenz M and Betge J and Schulte N and Zhan T and Hofheinz RD and Vogel A and Angermeier S and Bolling C and de Wit M and Jakobs R and Karthaus M and Stocker G and Thuss-Patience P and Leidig T and Bauer H and Ebert MP and Haertel N},
  year = {2024},
  journal = {Journal of geriatric oncology},
  doi = {10.1016/j.jgo.2024.101838},
  url = {https://doi.org/10.1016/j.jgo.2024.101838}
}

RIS

TY  - JOUR
TI  - Functional status and quality of life in older patients with advanced esophageal squamous cell cancer receiving second-line nivolumab ± ipilimumab therapy: A post hoc analysis of the phase 2, multicenter RAMONA study.
AU  - Li M
AU  - Meindl-Beinker NM
AU  - Maenz M
AU  - Betge J
AU  - Schulte N
AU  - Zhan T
AU  - Hofheinz RD
AU  - Vogel A
AU  - Angermeier S
AU  - Bolling C
AU  - de Wit M
AU  - Jakobs R
AU  - Karthaus M
AU  - Stocker G
AU  - Thuss-Patience P
AU  - Leidig T
AU  - Bauer H
AU  - Ebert MP
AU  - Haertel N
PY  - 2024
JO  - Journal of geriatric oncology
DO  - 10.1016/j.jgo.2024.101838
UR  - https://doi.org/10.1016/j.jgo.2024.101838
ER  -

APA

M, L., NM, M., M, M., J, B., N, S., T, Z., RD, H., A, V., S, A., C, B., M, D. W., R, J., M, K., G, S., P, T., T, L., H, B., MP, E., & N, H. (2024). Functional status and quality of life in older patients with advanced esophageal squamous cell cancer receiving second-line nivolumab ± ipilimumab therapy: A post hoc analysis of the phase 2, multicenter RAMONA study.. Journal of geriatric oncology. https://doi.org/10.1016/j.jgo.2024.101838

Source records

pubmed · retrieved 2026-09-25T16:50:40.906Z